ReviewDiagnostic potential of breath analysis—focus on volatile organic compounds
Introduction
Analysis of exhaled air enables the observation of biochemical processes in the body in a noninvasive window. The ancient Greek physicians already knew that some diseases could be diagnosed from the characteristic odour of patients' breath. Modern breath analysis started in the 1970s when Pauling et al. [1] determined more than 200 components in human breath using gas chromatography. For more than one decade, the main problems consisted of substance separation and identification. Due to the technical progress of analytical methods achieved in the 1980s and 1990s, these problems could finally be solved, and issues concerning the physiological meaning of the volatile substances and correlations of breath markers with patients' clinical conditions became more and more important [2]. Introducing breath analysis into clinical practice will be the challenge of today and tomorrow.
The bulk matrix of breath is a mixture of nitrogen, oxygen, carbon dioxide, water, and inert gases. The remaining small fraction of human breath consists of trace components occurring in concentrations in the nmol/l–pmol/l (ppbv–pptv) range. Far more than 500 of these compounds have been described. These volatile substances may be generated in the body or may be absorbed as contaminants from the environment. Exogenous molecules, especially halogenated organic compounds, may be analyzed for environmental or expositional issues to assess compound-specific uptake into the body and elimination from the body [3]. In order to monitor metabolic or any pathologic processes in the body, endogenous substances have to be determined.
These endogenous compounds include inorganic gases, such as NO, CO, volatile organic compounds (VOCs) such as ethane, pentane, acetone, isoprene, and other normally nonvolatile substances such as isoprostanes, peroxynitrite or cytokines that can be determined in breath condensate.
During the last two decades, NO has been recognized as a mediator of numerous physiological processes and as a marker of airway inflammation. Exhaled NO can now be determined by commercially available devices and has therefore been investigated in a large number of studies. Exhalation kinetics and relationships with airway diseases have been described in detail [4], [5], [6], [7], [8].
A number of normally nonvolatile substances, such as isoprostanes, cytokines, leukotrienes, or hydrogen peroxide can be found in breath condensate [7], [9].
Quantitative analysis of breath condensate is hampered by a number of serious problems. There is no clear relationship between assumed alveolar or airway concentrations and substance concentrations in the condensate [10]. Furthermore, some of these compounds only have limited stability.
Volatile organic substances such as ethane, pentane, isoprene, or acetone can provide insights into different biochemical processes in the healthy and the diseased human body. In contrast to the nonvolatile substances in breath condensate exhalation, kinetics of volatile organic substances can be approximated according to substance solubilities. In addition, for most of the exhaled organic compounds, there is no problem of stability.
This review is intended to describe the diagnostic potential of endogenous organic volatile substances in human breath. Analytical procedures, problems concerning the physiological meaning of breath markers, and future developments will be discussed.
Section snippets
Origin and properties of endogenous volatile organic biomarkers
Far more than 500 different volatile organic compounds can be detected in the human breath. Most of them however are not of endogenous origin. Endogenous markers, which are commonly used for diagnostic purposes, are hydrocarbons like ethane, pentane and isoprene; oxygen-containing compounds like acetone, acetaldehyde, methanol, ethanol, and 2-propanol; sulphur-containing compounds like dimethylsulfide, methyl, and ethyl mercaptanes; and carbon disulfide and nitrogen-containing substances like
Technical and methodical aspects of breath analysis
Despite a number of very promising results revealing interesting diagnostic properties of different markers, analysis of volatile organic compounds in breath has not yet been introduced into clinical practice. The main obstacles are technical problems, such as sampling, preconcentration, and analysis, as well as basic methodological issues such as normalization and expression of data.
Generally accepted standards of sampling, preconcentration, and analysis do not exist. Hence, reproducibility
Breath markers in certain diseases
During the last decade, a great number of clinical studies have been undertaken exploring the relationships between the chemical composition of exhaled air and patients' clinical status. Main targets of these investigations were different lung diseases, inflammatory and malignant processes in the body, and special diseased states such as allograft rejection and renal failure.
Problems and requirements of breath testing are different depending on whether longitudinal or cross-sectional studies
Conclusion
Breath analysis has attracted a considerable amount of scientific and clinical interest. The large number of studies undertaken during the last decade may convey an idea of the diagnostic potential of exhaled breath markers. In contrast to NO, which is predominantly generated in the bronchial system, volatile organic compounds are mainly blood borne and therefore enable monitoring of different processes in the body. Single substances or sets and patterns of exhaled markers were investigated in
References (108)
- et al.
Exhaled monoxides as a pulmonary function test: use of exhaled nitric oxide and carbon monoxide
Clin. Chest Med.
(2001) - et al.
Breath alkanes as a marker of oxidative stress in different clinical conditions
Free Radic. Biol. Med.
(2000) - et al.
Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. A randomized controlled trial
Am. J. Gastroenterol.
(2003) - et al.
Increased oxidative stress in younger as well as in older humans
Clin. Chim. Acta
(2003) - et al.
Clinical application of breath biomarkers of oxidative stress status
Free Radic. Biol. Med.
(1999) - et al.
Is n-pentane really an index of lipid peroxidation in humans and animals? A methodological reevaluation
Anal. Biochem.
(1993) - et al.
In vitro biosynthesis of isoprene from mevalonate utilizing a rat liver cytosolic fraction
Biochem. Biophys. Res. Commun.
(1984) - et al.
Characterization of aspen isoprene synthase, an enzyme responsible for leaf isoprene emission to the atmosphere
J. Biol. Chem.
(1995) - et al.
Acid-catalyzed formation of isoprene from a mevalonate-derived product using a rat liver cytosolic fraction
J. Biol. Chem.
(1985) - et al.
Blood isoprene concentrations in humans and some animal species
Biochem. Med. Metab. Biol.
(1992)
Diabetic ketoacidosis
Lancet
Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis
Gastroenterology
The regulation of transaminative flux of methionine in rat liver mitochondria
Arch. Biochem. Biophys.
Quantitative analysis of ammonia on the breath of patients in end-stage renal failure
Kidney Int.
Method for he collection and assay of volatile organic compounds in breath
Anal. Biochem.
Measurement of volatile organic compounds in exhaled breath as collected in evacuated electropolished canisters
J. Chromatogr. B
Method for analysis of exhaled air by microwave energy desorption coupled with gas chromatography–flame ionization detection–mass spectrometry
J. Chromatogr. B Biomed. Sci. Appl.
Concentrating breath samples using liquid nitrogen: a reliable method for the simultaneous determination of ethane and pentane
Anal. Biochem.
Plasma vitamin E and selenium and breath pentane in home parenteral nutrition patients
Am. J. Clin. Nutr.
Breath alkanes as a marker of oxidative stress in different clinical conditions
Free Radic. Biol. Med.
Pitfalls in the use of breath pentane measurements to assess lipid peroxidation
J. Lipid Res.
Is endogenous isoprene the only coeluting compound in the measurement of breath pentane?
Clin. Chim. Acta
Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors
Biosens. Bioelectron.
Variation in volatile organic compounds in the breath of normal humans
J. Chromatogr. B
Exhaled pentane levels in acute asthma
Chest
Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea
Chest
Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection
J. Heart Lung Transplant.
Detection of lung cancer with volatile markers in the breath
Chest
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study
Lancet
Breath ethane: a specific indicator of free-radical-mediated lipid peroxidation following reperfusion of the ischemic liver
Free Radic. Biol. Med.
Visceral lipid peroxidation occurs at reperfusion after supraceliac aortic cross-clamping
J. Vasc. Surg.
Breath pentane and plasma lipid peroxides in ischemic heart disease
Free Radic. Biol. Med.
High breath pentane concentrations during acute myocardial infarction
Lancet
Oxidative stress and inflammation in hemodialysis patients
Am. J. Kidney Dis.
Breath ethane in dialysis patients and control subjects
Free Radic. Biol. Med.
Breath pentane concentrations during labor and the effect of epidural analgesia on the pentane concentration
Int. J. Obstet. Anesth.
Decrease in lipid peroxidation measured by breath pentane output in normals after oral supplementation with vitamin E
Clin. Nutr.
Elevated breath pentane in heart failure reduced by free radical scavenger
Free Radic. Biol. Med.
Antioxidant vitamin supplemaentation in Crohn's disease decreases oxidative stress. A randomized controlled trial
Am. J. Gastroenterol.
Oxidative stress, exercise, and antioxidant supplementation
Toxicology
Quantitative analysis of urine vapour and breath by gas–liquid partition chromatography
Proc. Natl. Acad. Sci. U. S. A.
The diagnostic potential of breath analysis
Clin. Chem.
Exhaled human breath measurement method for assessing exposure to halogenated volatile organic compounds
Clin. Chem.
Exhaled nitric oxide as a marker in asthma
Eur. Respir. J. Suppl.
Role of exhaled nitric oxide in asthma
Immunol. Cell Biol.
Biomarkers of some pulmonary diseases in exhaled breath
Biomarkers
Multiple roles of nitric oxide in the airways
Thorax
Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate
Eur. Respir. J.
Dilution of respiratory solutes in exhaled condensates
Am. J. Respir. Crit. Care Med.
Breath markers and soluble lipid peroxidation markers in critically ill patients
Clin. Chem. Lab. Med.
Cited by (891)
Electrical gas sensors based on metal–organic frameworks for breath diagnosis
2024, Microchemical JournalVolatile organic compounds for diagnosis of early hepatocellular carcinoma in at-risk patients
2024, Clinica Chimica ActaApplication of metal-organic frameworks for sensing of VOCs and other volatile biomarkers
2024, Coordination Chemistry Reviews